Education Lab/CME

IBD Summit
CME

Best of IBD Summit for Fellows

This activity is supported by independent educational grants from AbbVie; Pfizer; Salix Pharmaceuticals; and Takeda Pharmaceuticals U.S.A., Inc.

Expiration Date: 1/23/2019
Credit Type(s): CME | Credit: 1.5

Inflammatory bowel disease (IBD) is a chronic, frequently progressive condition that affects approximately 1 to 1.3 million people in the United States. There is…

go to activity»
Highlights of the IBD Summit for Fellows
CME

Highlights of the IBD Summit for Fellows

This activity is supported by independent educational grants from AbbVie; Pfizer; Salix Pharmaceuticals; and Takeda Pharmaceutical U.S.A., Inc.

Expiration Date: 12/15/2018
Credit Type(s): CME | Credit: 1.25

Inflammatory bowel disease (IBD) is a chronic, frequently progressive condition that affects approximately 1 to 1.3 million people in the United States. The outcomes of…

go to activity»
Addressing Common Patient Concerns Regarding Biosimilars
CMECPE

Addressing Common Patient Concerns Regarding Biosimilars

This activity is supported by an educational grant from Pfizer, Inc.

Expiration Date: 12/19/2018
Credit Type(s): CME / CPE | Credit: 0.25

As more biosimilars are approved for use in the United States, greater emphasis is needed on educating patients about their treatment options, the use of biosimilars…

go to activity»
But How Similar is it? What You Need to Know and What to Tell Your Patients About Biosimilars
CMECPE

But How Similar is it? What You Need to Know and What to Tell Your Patients About Biosimilars

This activity is supported by an educational grant from Pfizer, Inc.

Expiration Date: 12/19/2018
Credit Type(s): CPE / CME | Credit: 1

As more biosimilars are approved for use in the United States, all members of the multidisciplinary care team will require education about the appropriate incorporation…

go to activity»
CME

Best of IBD Forum

This activity is supported by independent educational grants from AbbVie, Inc.; Pfizer, Inc.; Takeda Pharmaceuticals U.S.A., Inc.; and UCB, Inc.

Expiration Date: 11/26/2018
Credit Type(s): CME | Credit: 1.5

Inflammatory bowel disease (IBD) is a chronic, frequently progressive condition that affects approximately 1 to 1.3 million people in the United States. Substantial room…

go to activity»
A 52-Year-Old Black Female Who Presented to Her Primary Care Physician (PCP) With Increasing Fatigue and Muscle Aches
CMEABIM MOC

Ace the Case: A 52-Year-Old Black Female Who Presented to Her Primary Care Physician (PCP) With Increasing Fatigue and Muscle Aches

No commercial support for this activity.

Expiration Date: 10/15/2018
Credit Type(s): CME / ABIM MOC | Credit: 0.25

This educational activity will utilize a case study to discuss a 52-year-old black female who presented to her primary care physician (PCP) with increasing fatigue and…

go to activity»
Esophageal reflux
CMEABIM MOC

Ace the Case: A 52-Year-Old Male with Type 2 Diabetes Presents with Moderate Esophageal Reflux

No commercial support for this activity.

Expiration Date: 1/14/2019
Credit Type(s): ABIM MOC / CME | Credit: 0.25

This educational activity will utilize a case study to discuss obesity management in a 52-year-old male with T2DM, obesity and multiple comorbidities….

go to activity»
HEA039
CMEABIM MOC

Ace the Case: A 67-year-old Asian Woman Presents to the Emergency Department for 4 Days of Non-Bloody Diarrhea, Decreased PO Intake, and Lightheadedness

There is no commercial support for this activity.

Expiration Date: 12/31/2018
Credit Type(s): CME / ABIM MOC | Credit: 0.25

This “Ace the Case” study will discuss the treatment of an elderly woman who presents to the emergency room with 4 days of non-bloody diarrhea, decreased PO intake, and…

go to activity»
Overcoming Barriers and Best Practices for Use of Biosimilars: Conversations Between Physicians and Pharmacists
CMECPE

Overcoming Barriers and Best Practices for Use of Biosimilars: Conversations Between Physicians and Pharmacists

This activity is supported by an educational grant from Pfizer, Inc.

Expiration Date: 12/19/2018
Credit Type(s): CME / CPE | Credit: 0.5

As more biosimilars are approved for use in the United States, all members of the multidisciplinary care team will require education about the appropriate incorporation…

go to activity»
HEA038
CMEABIM MOC

Ace the Case: 32-Year-Old Male Originally Diagnosed with Chronic Hepatitis C Virus (HCV) genotype 1a (G1a) in 2012 and Relapsed

No commercial support for this activity.

Expiration Date: 11/14/2018
Credit Type(s): ABIM MOC / CME | Credit: 0.25

This “Ace the Case” activity will discuss the treatment of a patient originally diagnosed with chronic hepatitis C virus (HCV) genotype 1a (G1a) and relapsed….

go to activity»
activity image
CMECECPE

Deep Remission, Mucosal Healing, and Top-Down Treatment Strategies in Ulcerative Colitis: An Infographic Journey

Expiration Date: 7/31/2018
Credit Type(s): CME / Pharmacy | Credit: 1

Ulcerative colitis (UC) is an inflammatory bowel disease with a progressive course characterized by exacerbations and remissions. Traditionally, the goals of therapy for…

go to activity»
Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients' Quality-of-Life
CME

Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients' Quality-of-Life

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Pancreas Foundation.

Expiration Date: 8/15/2018
Credit Type(s): CME | Credit: 0.75

Familial chylomicronemia syndrome (FCS) is a rare and potentially life-threatening genetic disease. The clinical hallmark of FCS is pancreatitis associated with marked…

go to activity»